See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $51.0B | 3.0x | 10.2x | |
| $3.1B | 6.0x | 17.3x | |
| $3.1B | n/a | n/a | |
| $2.7B | 9.9x | -32.4x | |
| $2.4B | 2.8x | 14.0x | |
| $2.3B | 30.8x | -17.2x | |
| $2.3B | 9.9x | 39.3x | |
| $2.2B | 0.9x | 6.4x | |
| $1.9B | 78.5x | n/a | |
| $1.9B | 6.5x | 13.5x | |
| $1.7B | 6.8x | 19.7x | |
| $1.4B | 6.7x | n/a | |
| $1.3B | 8.0x | 78.9x | |
| $1.2B | 8.9x | -29.7x | |
| $1.1B | 8.8x | 20.4x | |
| $818M | n/a | n/a | |
| $720M | 6.2x | 35.3x | |
| $714M | n/a | -26.9x | |
| $695M | 3.1x | 22.8x | |
| $675M | 5.4x | n/a | |
| $629M | 28.8x | n/a | |
| $597M | 15.3x | -9.5x | |
| $583M | 6.7x | 19.4x | |
| $556M | 1.9x | 4.5x | |
| $515M | n/a | -6.3x | |
| $269M | 150.0x | -63.5x | |
| $262M | 30.6x | n/a | |
| $236M | 2.2x | 96.8x | |
| $172M | n/a | -6.2x | |
| $151M | 6.6x | -5.9x | |
| $117M | n/a | n/a | |
| $116M | 0.4x | 3.7x | |
| $78.6M | 4.5x | n/a | |
| $59.4M | 5.6x | n/a | |
| $52.7M | 1.7x | n/a | |
| $39.1M | n/a | -0.4x | |
| $25.5M | 0.4x | 1.4x | |
| $0.8M | 2.2x | n/a | |
| -$86.0M | n/a | 0.6x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules